BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 24714917)

  • 1. Enhanced efficacy of combination therapy with adeno‑associated virus-delivered pigment epithelium-derived factor and cisplatin in a mouse model of Lewis lung carcinoma.
    He SS; Wu QJ; Gong CY; Luo ST; Zhang S; Li M; Lu L; Wei YQ; Yang L
    Mol Med Rep; 2014 Jun; 9(6):2069-76. PubMed ID: 24714917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AAV-mediated gene transfer of human pigment epithelium-derived factor inhibits Lewis lung carcinoma growth in mice.
    He SS; Shi HS; Yin T; Li YX; Luo ST; Wu QJ; Lu L; Wei YQ; Yang L
    Oncol Rep; 2012 Apr; 27(4):1142-8. PubMed ID: 22218393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adeno-associated virus vector-mediated delivery of pigment epithelium-derived factor restricts neuroblastoma angiogenesis and growth.
    Streck CJ; Zhang Y; Zhou J; Ng C; Nathwani AC; Davidoff AM
    J Pediatr Surg; 2005 Jan; 40(1):236-43. PubMed ID: 15868591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AAV-mediated human PEDF inhibits tumor growth and metastasis in murine colorectal peritoneal carcinomatosis model.
    Wu QJ; Gong CY; Luo ST; Zhang DM; Zhang S; Shi HS; Lu L; Yan HX; He SS; Li DD; Yang L; Zhao X; Wei YQ
    BMC Cancer; 2012 Mar; 12():129. PubMed ID: 22462776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic antitumor effect of recombinant adeno-associated virus-mediated pigment epithelium-derived factor with hyperthermia on solid tumor.
    Wu Q; He S; Wei X; Shao B; Luo S; Guo F; Zhang H; Wang Y; Gong C; Yang L
    Hum Gene Ther; 2014 Sep; 25(9):811-23. PubMed ID: 25003563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of lung cancer in murine model: treated by combination of recombinant human endostsatin adenovirus with low-dose cisplatin.
    Bai RZ; Wu Y; Liu Q; Xie K; Wei YQ; Wang YS; Liu K; Luo Y; Su JM; Hu B; Liu JY; Li Q; Niu T; Zhao ZW; Yang L
    J Exp Clin Cancer Res; 2009 Mar; 28(1):31. PubMed ID: 19265510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic potential of bone marrow-derived mesenchymal stem cells producing pigment epithelium-derived factor in lung carcinoma.
    Chen Q; Cheng P; Yin T; He H; Yang L; Wei Y; Chen X
    Int J Mol Med; 2012 Sep; 30(3):527-34. PubMed ID: 22684097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AAV-mediated gene transfer of pigment epithelium-derived factor inhibits choroidal neovascularization.
    Mori K; Gehlbach P; Yamamoto S; Duh E; Zack DJ; Li Q; Berns KI; Raisler BJ; Hauswirth WW; Campochiaro PA
    Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):1994-2000. PubMed ID: 12037010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic antitumor effect of AAV-mediated TRAIL expression combined with cisplatin on head and neck squamous cell carcinoma.
    Jiang M; Liu Z; Xiang Y; Ma H; Liu S; Liu Y; Zheng D
    BMC Cancer; 2011 Feb; 11():54. PubMed ID: 21291526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Administration of pigment epithelium-derived factor delivered by adeno-associated virus inhibits blood-retinal barrier breakdown in diabetic rats.
    Yu H; Chen L; Jiang J
    Mol Vis; 2010 Nov; 16():2384-94. PubMed ID: 21139695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-tumor effect of adenovirus-mediated gene transfer of pigment epithelium-derived factor on mouse B16-F10 melanoma.
    Yang LP; Cheng P; Peng XC; Shi HS; He WH; Cui FY; Luo ST; Wei YQ; Yang L
    J Exp Clin Cancer Res; 2009 Jun; 28(1):75. PubMed ID: 19500366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pigment epithelial-derived factor gene loaded in PLGA nanoparticles for therapy of colon carcinoma.
    Cui FY; Song XR; Li ZY; Li SZ; Mu B; Mao YQ; Wei YQ; Yang L
    Oncol Rep; 2010 Sep; 24(3):661-8. PubMed ID: 20664971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of combination therapy using adeno-associated virus-TRAIL targeting to telomerase activity and cisplatin in a mice model of hepatocellular carcinoma.
    Wang Y; Huang F; Cai H; Wu Y; He G; Tan WS
    J Cancer Res Clin Oncol; 2010 Dec; 136(12):1827-37. PubMed ID: 20213096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-tumor efficacy of human angiostatin using liver-mediated adeno-associated virus gene therapy.
    Lalani AS; Chang B; Lin J; Case SS; Luan B; Wu-Prior WW; VanRoey M; Jooss K
    Mol Ther; 2004 Jan; 9(1):56-66. PubMed ID: 14741778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of pigment epithelium-derived factor with radiotherapy enhances the antitumor effects on nasopharyngeal carcinoma by downregulating vascular endothelial growth factor expression and angiogenesis.
    Xu Z; Fang S; Zuo Y; Zhang Y; Cheng R; Wang Q; Yang Z; Cai W; Ma J; Yang X; Gao G
    Cancer Sci; 2011 Oct; 102(10):1789-98. PubMed ID: 21707863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraocular route of AAV2 vector administration defines humoral immune response and therapeutic potential.
    Li Q; Miller R; Han PY; Pang J; Dinculescu A; Chiodo V; Hauswirth WW
    Mol Vis; 2008 Sep; 14():1760-9. PubMed ID: 18836574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene transfer of pigment epithelium-derived factor suppresses tumor growth and angiogenesis in a hepatoblastoma xenograft model.
    Browne M; Stellmach V; Cornwell M; Chung C; Doll JA; Lee EJ; Jameson JL; Reynolds M; Superina RA; Abramson LP; Crawford SE
    Pediatr Res; 2006 Sep; 60(3):282-7. PubMed ID: 16857775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic neuroprotective effect via simian lentiviral vector-mediated simultaneous gene transfer of human pigment epithelium-derived factor and human fibroblast growth factor-2 in rodent models of retinitis pigmentosa.
    Miyazaki M; Ikeda Y; Yonemitsu Y; Goto Y; Kohno R; Murakami Y; Inoue M; Ueda Y; Hasegawa M; Tobimatsu S; Sueishi K; Ishibashi T
    J Gene Med; 2008 Dec; 10(12):1273-81. PubMed ID: 18837062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pigment epithelium-derived factor gene therapy inhibits human pancreatic cancer in mice.
    Hase R; Miyamoto M; Uehara H; Kadoya M; Ebihara Y; Murakami Y; Takahashi R; Mega S; Li L; Shichinohe T; Kawarada Y; Kondo S
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8737-44. PubMed ID: 16361561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue-targeted and localized AAV5-DCN and AAV5-PEDF combination gene therapy abrogates corneal fibrosis and concurrent neovascularization in rabbit eyes in vivo.
    Mohan RR; Gupta S; Kumar R; Sinha NR; Landreneau J; Sinha PR; Tandon A; Chaurasia SS; Hesemann NP
    Ocul Surf; 2024 Apr; 32():13-25. PubMed ID: 38191093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.